I-CELL DISEASE AND MENTAL RETARDATION

I-CELL 疾病和智力低下

基本信息

  • 批准号:
    3394735
  • 负责人:
  • 金额:
    $ 16.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1978
  • 资助国家:
    美国
  • 起止时间:
    1978-06-01 至 1987-11-30
  • 项目状态:
    已结题

项目摘要

Lysosomal enzymes share a unique pathway of biosynthesis and posttranslational modification. The long-term objectives of this grant involve studies of structural information on acid hydrolases which is necessary for their intracellular sorting and subsequent targeting to lysosomes or extracellular fluids. I-cell disease (ICD) and pseudoHurler polydystrophy (PHP), two inherited childhood disorders, will be used as model systems. The primary defect responsible for these disorders is an absence or severe reduction of glcNac phosphotransferase, a key enzyme involved in the biosynthesis and targeting of acid hydrolases to lysosomes. Evidence exists for genetic and biochemical heterogeneity in ICD and PHP. The existence of complementation groups within and between the two disorders suggest the involvement of more than one gene mutation which affects the structure and function of the transferase. One experimental approach will examine selected properties of the enzyme from the different complementation groups, such as the enzyme's stability under various conditions including temperature, addition of protease inhibitors, sucrose loading, and the enzyme's interaction with various lectins. The purification of the transferase from autopsied human liver will be carried out using a combination of conventional and affinity column methods. The characterization of kinetic, chemical, and physical properties of the enzyme from both the normal and mutant sources will be useful in understanding the functions of the different gene product(s) required for enzyme activity. The production of polyclonal antisera will allow us to probe the basis for each mutation by comparing the biosynthesis and processing of immunoprecipitable material in normal and mutant cell lines after adding labeled amino acids or 3H mannose. Lymphoblasts prepared from normal controls, ICD and PHP patients will also be examined as an alternate source to study the glcNac phosphotransferase protein from the various complementation groups. A second approach in studying the structural requirements for intracellular segregation of acid hydrolases will employ cultured normal, ICD, and PHP skin fibroblasts and lymphoblasts that have been previously pulsed with 3H-mannose and grown in the presence or absence of various agents known to interfere with normal glycosylation (tunicamycin), posttranslational processing (swainsonine) and intracellular transport and secretion (monensin). Subcellular fractionation by density gradient centrifugation on percoll and/or free flow electrophoresis will allow separation of the fractions containing labeled acid hydrolases and subsequent analysis of the types of oligosaccharides present.
溶酶体酶有着独特的生物合成途径, 翻译后修饰 这项补助金的长期目标 涉及对酸性水解酶的结构信息的研究, 对于它们的细胞内分选和随后的靶向, 溶酶体或细胞外液。 I-细胞病(ICD)和假性Hurler 多发性营养不良(PHP),两种遗传性儿童疾病,将被用作 模型系统 导致这些疾病的主要缺陷是 glcNac磷酸转移酶(一种关键酶)缺失或严重减少 参与酸性水解酶的生物合成和靶向, 溶酶体 有证据表明, ICD和PHP。 互补群的存在 这两种疾病暗示了不止一种基因突变的参与 其影响转移酶的结构和功能。 一 实验方法将检查酶的选定特性, 不同的互补基团,如酶的稳定性下, 各种条件包括温度,加入蛋白酶抑制剂, 蔗糖负载,以及酶与各种凝集素的相互作用。 的 将从尸检的人肝脏中纯化转移酶, 使用常规和亲和柱方法的组合。 的 表征的动力学,化学和物理性质的 来自正常和突变体来源的酶将可用于 了解不同基因产物的功能, 酶活性 多克隆抗血清的生产将使我们能够 通过比较生物合成和 正常和突变细胞系中免疫可沉淀物质的处理 加入标记氨基酸或3 H甘露糖后。 淋巴母细胞制备自 正常对照、ICD和PHP患者也将作为替代检查 来源研究glcNac磷酸转移酶蛋白从各种 互补群 第二种研究结构的方法 酸性水解酶的细胞内分离的要求将采用 培养的正常、ICD和PHP皮肤成纤维细胞和淋巴母细胞, 预先用3 H-甘露糖脉冲并在存在或不存在下生长 已知干扰正常糖基化的各种试剂 (衣霉素),翻译后加工(苦马豆素)和细胞内 运输和分泌(莫能菌素)。 密度亚细胞分级 梯度离心法和/或自由流电泳法 允许分离含有标记的酸性水解酶的级分, 随后分析存在的寡糖的类型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARNOLD L MILLER其他文献

ARNOLD L MILLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARNOLD L MILLER', 18)}}的其他基金

TURNOVER OF SUBSTANCES IN THE OUTFLOW PATHWAY OF THE EYE
眼睛流出通道中的物质周转
  • 批准号:
    3263908
  • 财政年份:
    1988
  • 资助金额:
    $ 16.12万
  • 项目类别:
TURNOVER OF SUBSTANCES IN THE OUTFLOW PATHWAY OF THE EYE
眼睛流出通道中的物质周转
  • 批准号:
    3263909
  • 财政年份:
    1988
  • 资助金额:
    $ 16.12万
  • 项目类别:
TURNOVER OF SUBSTANCES IN THE OUTFLOW PATHWAY OF THE EYE
眼睛流出通道中的物质周转
  • 批准号:
    3263905
  • 财政年份:
    1988
  • 资助金额:
    $ 16.12万
  • 项目类别:
I-CELL DISEASE AND MENTAL RETARDATION
I-CELL 疾病和智力低下
  • 批准号:
    3394741
  • 财政年份:
    1978
  • 资助金额:
    $ 16.12万
  • 项目类别:
I-CELL DISEASE AND MENTAL RETARDATION
I-CELL 疾病和智力低下
  • 批准号:
    3394745
  • 财政年份:
    1978
  • 资助金额:
    $ 16.12万
  • 项目类别:
I-CELL DISEASE AND MENTAL RETARDATION
I-CELL 疾病和智力低下
  • 批准号:
    2262393
  • 财政年份:
    1978
  • 资助金额:
    $ 16.12万
  • 项目类别:
I-CELL DISEASE AND MENTAL RETARDATION
I-CELL 疾病和智力低下
  • 批准号:
    3394742
  • 财政年份:
    1978
  • 资助金额:
    $ 16.12万
  • 项目类别:
I-CELL DISEASE AND MENTAL RETARDATION
I-CELL 疾病和智力低下
  • 批准号:
    3394744
  • 财政年份:
    1978
  • 资助金额:
    $ 16.12万
  • 项目类别:
I-CELL DISEASE AND MENTAL RETARDATION
I-CELL 疾病和智力低下
  • 批准号:
    3394740
  • 财政年份:
    1978
  • 资助金额:
    $ 16.12万
  • 项目类别:
I-CELL DISEASE AND MENTAL RETARDATION
I-CELL 疾病和智力低下
  • 批准号:
    2262392
  • 财政年份:
    1978
  • 资助金额:
    $ 16.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了